Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.

Details

Serval ID
serval:BIB_9A1B79DCDA94
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.
Journal
American Journal of Gastroenterology
Author(s)
Leblanc S., Allez M., Seksik P., Flourié B., Peeters H., Dupas J.L., Bouguen G., Peyrin-Biroulet L., Duclos B., Bourreille A., Dewit O., Bouhnik Y., Michetti P., Chaussade S., Saussure P., Mary J.Y., Colombel J.F., Lémann M.
ISSN
1572-0241 (Electronic)
ISSN-L
0002-9270
Publication state
Published
Issued date
2011
Volume
106
Number
4
Pages
771-777
Language
english
Abstract
OBJECTIVES: Rescue therapy with either cyclosporine (CYS) or infliximab (IFX) is an effective option in patients with intravenous steroid-refractory attacks of ulcerative colitis (UC). In patients who fail, colectomy is usually recommended, but a second-line rescue therapy with IFX or CYS is an alternative. The aims of this study were to investigate the efficacy and tolerance of IFX and CYS as a second-line rescue therapy in steroid-refractory UC or indeterminate colitis (IC) unsuccessfully treated with CYS or IFX.METHODS: This was a retrospective survey of patients seen during the period 2000-2008 in the GETAID centers. Inclusion criteria included a delay of <1 month between CYS withdrawal (when used first) and IFX, or a delay of <2 months between IFX (when used first) and CYS, and a follow-up of at least 3 months after inclusion. Time-to-colectomy, clinical response, and occurrence of serious adverse events were analyzed.RESULTS: A total of 86 patients (median age 34 years; 49 males; 71 UC and 15 IC) were successively treated with CYS and IFX. The median (+/-s.e.) follow-up time was 22.6 (7.0) months. During the study period, 49 patients failed to respond to the second-line rescue therapy and underwent a colectomy. The probability of colectomy-free survival (+/-s.e.) was 61.3 +/- 5.3% at 3 months and 41.3 +/- 5.6% at 12 months. A case of fatal pulmonary embolism occurred at 1 day after surgery in a 45-year-old man. Also, nine infectious complications were observed during the second-line rescue therapy.CONCLUSIONS: In patients with intravenous steroid-refractory UC and who fail to respond to CYS or IFX, a second-line rescue therapy may be effective in carefully selected patients, avoiding colectomy within 2 months in two-thirds of them. The risk/benefit ratio should still be considered individually.
Pubmed
Web of science
Create date
06/05/2011 12:48
Last modification date
20/08/2019 15:01
Usage data